Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Neovasc Inc. NVCN
$30.03
На 18:00, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
82859377.00000000
-
week52high
30.07
-
week52low
4.59
-
Revenue
3805017
-
P/E TTM
-6
-
Beta
2.01379900
-
EPS
-15.07000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 10:59
Описание компании
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| H.C. Wainwright | Buy | 25 ноя 2020 г. | |
| Canaccord Genuity | Buy | Buy | 25 ноя 2020 г. |
| SVB Leerink | Outperform | Outperform | 06 ноя 2020 г. |
| H.C. Wainwright | Buy | 08 мая 2020 г. | |
| Canaccord Genuity | Buy | Buy | 31 мар 2020 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
Mergers and Acquisitions in 2023 Off To A Strong Start
MarketBeat
27 янв 2023 г. в 08:17
Mergers and acquisitions are a normal part of business, but 2023 has already presented many opportunities across the biotech industry. The M&A surge seems to be driven by two major transactions: the $6 billion sale of LHC Group Inc. (Nasdaq: LHCG) to UnitedHealth (NYSE: UNH) and the $8 billion sale of Signify Health Inc. (NYSE: SGFY) to CVS Health Co. (NYSE: CVS).
Shockwave Medical To Buy Neovasc: Details (NVCN)
Pulse2
18 янв 2023 г. в 09:33
Neovasc announced that it is being acquired by Shockwave Medical. These are the details.
Neovasc (NVCN) is on the Move, Here's Why the Trend Could be Sustainable
Zacks Investment Research
11 янв 2023 г. в 10:32
Neovasc (NVCN) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.
Recent Price Trend in Neovasc (NVCN) is Your Friend, Here's Why
Zacks Investment Research
26 дек 2022 г. в 10:32
Neovasc (NVCN) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Neovasc (NVCN) Reports Q3 Loss, Misses Revenue Estimates
Zacks Investment Research
10 ноя 2022 г. в 21:49
Neovasc (NVCN) delivered earnings and revenue surprises of -6.38% and 7.70%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?